On the stock market since 2004, it operates in the world of health and science. It has 730 employees. Now — the numbers.
This is an established company with proven profits.
Average growth of 20% a year over the last 4 years. Every year shown ended in profit.
If every debt were paid off today, $366.0M would still be left in the vault — a solid cushion for hard times.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Profit power and business quality lead the class.
Debt is low and cash is strong; the finances stand solid.
The price isn’t cheap next to earnings — that’s why this grade sits in the middle.
Clearly below the class average.
The stock has been running stronger than the market lately.
Growth: Sales growth trails the sector average.
angles, checked one by one.
The 4 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Executive Buying: The trades send no strong signal of confidence.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
Over the last 3 years, sales grew about 24% a year on average.
There is $372.2M in the vault; even if every debt were paid off, $366.0M would remain.
The company’s market value is 122 times its annual profit. Even a small disappointment could hit the price hard.
The growth engine is running at low revs right now. Report-card grade: 40/100.
No clear buy-side message is coming from the executive floor. Council score: 3/10.
On our five-subject report card, CORT sits near the top of the class. A high grade doesn’t mean “guaranteed win” — it means “the evidence looks strong for now.”
The takeaway: CORT is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s what that quality should cost.
The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.